| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH | | | NDDHC 2020-1 (EUR 350m) | Stada Arzneimittel AG | | EMEA | Jan 30, 2020 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| HCN | 350.000 | 5.1 | Jun-09 | Si. Siqaiiq | - | - | - | Ppjgn | S | 100.50-101.00 | - | 391 | 3.50% | - | 137.00000 |
Tranche Comments 4.7 jf: Registration: 144H/Ihp Q; Comments: CVF350b fxr iu 3.5% Fur 2024 (Uxffs utib 9/20 50%/25%/rxt) . Ruts Axtr/ERQ(A&M). EAs VAF/Udfd/UQY/MA/AQR/Euuu/QF/Qib/FR. Fxfr 100.50-101.00, rxbu 101.00 p A+391 is VAB0% 10/24. QCU A+50.; Deal Comments DFD350n qcq sk 3.5% 9/30/24. Use of Proceeds Wtzjxdxzjxf |
|
